Vitale Giovanni, Colina Matteo, Attinà Domenico, Niro Fabio, Ortolani Paolo
Cardiology Unit, Ospedale Santa Maria della Scaletta, Imola, Italy.
Service of Rheumatology, Section of Internal Medicine, Department of Medicine and Oncology, Ospedale Santa Maria della Scaletta, Imola, Italy.
Front Med (Lausanne). 2025 Aug 15;12:1606593. doi: 10.3389/fmed.2025.1606593. eCollection 2025.
Systemic sclerosis (SSc) is a chronic, multisystem disorder characterized by vascular dysfunction, immune dysregulation with production of autoantibodies, fibroblasts dysfunction and consequent abnormal collagen production, leading to progressive fibrosis of the skin and various organs. Cardiac involvement is common, affecting the myocardium, pericardium, valvular structures and conduction tissue, even though it is often unrecognized. Despite this, it is a major determinant of morbidity and mortality in SSc, being responsible for about 15% of all deaths. Due to the relevant prognostic implications of cardiac involvement its early detection is mandatory. A comprehensive screening through a multimodality approach is required in all patients with SSc, even in those without overt cardiac symptoms. Cardiac magnetic resonance (CMR) is now considered the gold standard for non-invasive detection of the myocardial disease SSc related. It provides not only a morphological and functional assessment, but also offers an ultrastructural definition of the myocardium, particularly by the detection of fibrosis and myocardial inflammation (MI), unmasking an initial myocardial involvement since the early stage of disease. The aim of this review is to describe the potential spectrum of cardiac involvement in SSc, and to highlight central role of CMR in its detection, offering a comprehensive description of the imaging features and their prognostic implication.
系统性硬化症(SSc)是一种慢性多系统疾病,其特征为血管功能障碍、自身抗体产生导致的免疫失调、成纤维细胞功能障碍以及随之而来的异常胶原蛋白生成,进而导致皮肤和各种器官的进行性纤维化。心脏受累很常见,可累及心肌、心包、瓣膜结构和传导组织,尽管其往往未被识别。尽管如此,它仍是系统性硬化症发病率和死亡率的主要决定因素,约占所有死亡人数的15%。由于心脏受累具有重要的预后意义,因此必须早期检测。所有系统性硬化症患者,即使是那些没有明显心脏症状的患者,都需要通过多模态方法进行全面筛查。心脏磁共振成像(CMR)现在被认为是无创检测系统性硬化症相关心肌病的金标准。它不仅提供形态和功能评估,还能对心肌进行超微结构定义,特别是通过检测纤维化和心肌炎症(MI),揭示疾病早期的心肌受累情况。本综述的目的是描述系统性硬化症中心脏受累的潜在范围,并强调心脏磁共振成像在其检测中的核心作用,全面描述成像特征及其预后意义。